Stroke Recovery in Rats after 24‐Hour–Delayed Intramuscular Neurotrophin‐3 Infusion
Open Access
- 7 December 2018
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 85 (1) , 32-46
Abstract
Objective: Neurotrophin‐3 (NT3) plays a key role in the development and function of locomotor circuits including descending serotonergic and corticospinal tract axons and afferents from muscle and skin. We have previously shown that gene therapy delivery of human NT3 into affected forelimb muscles improves sensorimotor recovery after stroke in adult and elderly rats. Here, to move toward the clinic, we tested the hypothesis that intramuscular infusion of NT3 protein could improve sensorimotor recovery after stroke.Methods: Rats received unilateral ischemic stroke in sensorimotor cortex. To simulate a clinically feasible time to treatment, 24 hours later rats were randomized to receive NT3 or vehicle by infusion into affected triceps brachii for 4 weeks using implanted catheters and minipumps.Results: Radiolabeled NT3 crossed from the bloodstream into the brain and spinal cord in rodents with or without strokes. NT3 increased the accuracy of forelimb placement during walking on a horizontal ladder and increased use of the affected arm for lateral support during rearing. NT3 also reversed sensory impairment of the affected wrist. Functional magnetic resonance imaging during stimulation of the affected wrist showed spontaneous recovery of peri‐infarct blood oxygenation level–dependent signal that NT3 did not further enhance. Rather, NT3 induced neuroplasticity of the spared corticospinal and serotonergic pathways.Interpretation: Our results show that delayed, peripheral infusion of NT3 can improve sensorimotor function after ischemic stroke. Phase I and II clinical trials of NT3 (for constipation and neuropathy) have shown that peripheral high doses are safe and well tolerated, which paves the way for NT3 as a therapy for stroke. ANN NEUROL 2019;85:32–46.Keywords
Funding Information
- Biotechnology and Biological Sciences Research Council (Capacity Building Award in Integrative Mammalian B)
- British Pharmacological Society (Integrative Pharmacology Fund)
- Dowager Countess Eleanor Peel Trust (Improving arm function after stroke)
- H2020 European Research Council (309731)
- Medical Research Council Canada (G0600998)
- Scottish Funding Council (Capacity Building Award in Integrative Mammalian B)
This publication has 55 references indexed in Scilit:
- Delayed treatment with chondroitinase ABC promotes sensorimotor recovery and plasticity after stroke in aged ratsBrain, 2012
- Differential effects of brain‐derived neurotrophic factor and neurotrophin‐3 on hindlimb function in paraplegic ratsEuropean Journal of Neuroscience, 2011
- Local and Remote Growth Factor Effects after Primate Spinal Cord InjuryThe Journal of Neuroscience, 2010
- Sustained sensorimotor impairments after endothelin-1 induced focal cerebral ischemia (stroke) in aged ratsExperimental Neurology, 2010
- Muscle Injection of AAV-NT3 Promotes Anatomical Reorganization of CST Axons and Improves Behavioral Outcome following SCIJournal of Neurotrauma, 2009
- Immune activation is required for NT-3-induced axonal plasticity in chronic spinal cord injuryExperimental Neurology, 2008
- Early Prediction of Functional Recovery after Experimental Stroke: Functional Magnetic Resonance Imaging, Electrophysiology, and Behavioral Testing in RatsJournal of Neuroscience, 2008
- Vascularization of the Dorsal Root Ganglia and Peripheral Nerve of the Mouse: Implications for Chemical-Induced Peripheral Sensory NeuropathiesMolecular Pain, 2008
- Differential distribution of exogenous BDNF, NGF, and NT‐3 in the brain corresponds to the relative abundance and distribution of high‐affinity and low‐affinity neurotrophin receptorsJournal of Comparative Neurology, 1995
- Influences of neurotrophins on mammalian motoneurons in vivoJournal of Neurobiology, 1993